Challenges in the management of bone metastases: focus on differentiated thyroid cancer and neuroendocrine tumors

Read full text Summarise with VIRAT
Authors: Julie Chen, Joy Y. Wu
Cited by: 0
References: 63

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Bone metastases represent an uncommon but clinically significant complication in endocrine malignancies including differentiated thyroid cancer and neuroendocrine tumors. Although these malignancies typically follow an indolent course, the development of bone metastases is associated with a worse prognosis and increased risk of skeletal-related events. The optimal strategies for the prevention and management of bone metastases in these patients remain unclear and are largely extrapolated from studies in other solid tumors. This presents a unique clinical challenge as treatment decisions need to balance the prevention of skeletal-related events against the potential risks of prolonged antiresorptive therapy in patients expected to have a long survival time. This article reviews the clinical complexities involved in managing bone metastases in differentiated thyroid cancer and neuroendocrine tumors. The clinical cases presented highlight key considerations to guide clinical decision-making when treating these specific patient populations.

Fields of Study & Subjects

Bone health and treatments Thyroid Cancer Diagnosis and Treatment Bone health and osteoporosis research

Publication details

Journal / source
Journal of the Endocrine Society
Volume
10
Issue
5
Pages
bvag065–bvag065
Publication date
24 March 2026
Language
EN